Nostrum Loses Asthma Drug FDA Fight At DC Circ.
The District of Columbia Circuit Court has shot down an appeal in Nostrum Pharmaceuticals LLC's fight with the U.S. Food and Drug Administration on how it could produce a would-be generic...To view the full article, register now.
Already a subscriber? Click here to view full article